Comment on "Ten-year survival outcomes of concurrent chemoradiotherapy with or without adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma in the IMRT era: A retrospective cohort study stratified by high- and low-risk profiles".
作者信息
Topkan Erkan, Somay Efsun, Ozturk Duriye, Selek Ugur
机构信息
Department of Radiation Oncology, Faculty of Medicine, Baskent University, Adana, Turkey.
Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Baskent University, Ankara, Turkey.
出版信息
Clin Transl Radiat Oncol. 2025 Jul 29;54:101025. doi: 10.1016/j.ctro.2025.101025. eCollection 2025 Sep.
Abstract
摘要
相似文献
1
Comment on "Ten-year survival outcomes of concurrent chemoradiotherapy with or without adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma in the IMRT era: A retrospective cohort study stratified by high- and low-risk profiles".对“调强放疗时代局部晚期鼻咽癌同步放化疗联合或不联合辅助化疗的十年生存结局：一项按高风险和低风险分层的回顾性队列研究”的评论
Clin Transl Radiat Oncol. 2025 Jul 29;54:101025. doi: 10.1016/j.ctro.2025.101025. eCollection 2025 Sep.
2
Ten-year survival outcomes of concurrent chemoradiotherapy with or without adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma in the IMRT era: A retrospective cohort study stratified by high- and low-risk profiles.调强放疗时代局部晚期鼻咽癌同步放化疗联合或不联合辅助化疗的10年生存结局：一项按高风险和低风险特征分层的回顾性队列研究
Clin Transl Radiat Oncol. 2025 Jun 27;54:101006. doi: 10.1016/j.ctro.2025.101006. eCollection 2025 Sep.
3
Induction chemotherapy plus IMRT alone versus induction chemotherapy plus IMRT-based concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.局部晚期鼻咽癌诱导化疗加 IMRT 与诱导化疗加基于 IMRT 的同期放化疗的回顾性队列研究。
J Cancer Res Clin Oncol. 2019 Jul;145(7):1857-1864. doi: 10.1007/s00432-019-02925-z. Epub 2019 May 6.
4
A Bayesian network meta-analysis comparing concurrent chemoradiotherapy followed by adjuvant chemotherapy, concurrent chemoradiotherapy alone and radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma.贝叶斯网状meta 分析比较局部晚期鼻咽癌患者同步放化疗后辅助化疗、单纯同步放化疗和单纯放疗的疗效。
Ann Oncol. 2015 Jan;26(1):205-211. doi: 10.1093/annonc/mdu507. Epub 2014 Oct 29.
5
Ten-year outcomes of IMRT with chemotherapy versus IMRT alone for stage II-IVa nasopharyngeal carcinoma: a retrospective study.调强放射治疗联合化疗与单纯调强放射治疗用于II-IVa期鼻咽癌的十年疗效：一项回顾性研究
Discov Oncol. 2025 Jul 19;16(1):1378. doi: 10.1007/s12672-025-03230-7.
6
Induction vs Adjuvant Chemoradiotherapy in Patients With High-Risk N2 to N3 Nasopharyngeal Carcinoma: A Phase 3 Randomized Clinical Trial.高危N2至N3期鼻咽癌患者诱导化疗与辅助放化疗的比较：一项3期随机临床试验
JAMA Oncol. 2025 Jun 18. doi: 10.1001/jamaoncol.2025.1597.
7
Induction Chemotherapy Followed by Radiotherapy vs Chemoradiotherapy in Nasopharyngeal Carcinoma: A Randomized Clinical Trial.诱导化疗后放疗与放化疗治疗鼻咽癌的随机临床试验
JAMA Oncol. 2024 Apr 1;10(4):456-463. doi: 10.1001/jamaoncol.2023.6552.
8
Gemcitabine and cisplatin versus docetaxel and cisplatin as induction chemotherapy followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma from non-endemic area of China.吉西他滨和顺铂与多西他赛和顺铂作为诱导化疗，随后在非中国鼻咽癌高发地区进行同期放化疗治疗局部晚期鼻咽癌。
J Cancer Res Clin Oncol. 2020 Sep;146(9):2369-2378. doi: 10.1007/s00432-020-03229-3. Epub 2020 May 3.
9
Tislelizumab and GP regimen neoadjuvant therapy followed by concurrent chemoradiotherapy with nimotuzumab in patients with stage IVA nasopharyngeal carcinoma: a retrospective study.替雷利珠单抗与GP方案新辅助治疗后联合尼妥珠单抗同步放化疗用于IVA期鼻咽癌患者：一项回顾性研究
Cancer Immunol Immunother. 2025 Jun 17;74(8):241. doi: 10.1007/s00262-025-04100-5.
10
The Changing Therapeutic Role of Chemo-radiotherapy for Loco-regionally Advanced Nasopharyngeal Carcinoma from Two/Three-Dimensional Radiotherapy to Intensity-Modulated Radiotherapy: A Network Meta-Analysis.从二维/三维放疗到调强放疗：局部晚期鼻咽癌化放疗治疗作用的变化：一项网状荟萃分析。
Theranostics. 2017 Oct 17;7(19):4825-4835. doi: 10.7150/thno.21815. eCollection 2017.
本文引用的文献
1
Ten-year outcomes of IMRT with chemotherapy versus IMRT alone for stage II-IVa nasopharyngeal carcinoma: a retrospective study.调强放射治疗联合化疗与单纯调强放射治疗用于II-IVa期鼻咽癌的十年疗效：一项回顾性研究
Discov Oncol. 2025 Jul 19;16(1):1378. doi: 10.1007/s12672-025-03230-7.
2
Ten-year survival outcomes of concurrent chemoradiotherapy with or without adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma in the IMRT era: A retrospective cohort study stratified by high- and low-risk profiles.调强放疗时代局部晚期鼻咽癌同步放化疗联合或不联合辅助化疗的10年生存结局：一项按高风险和低风险特征分层的回顾性队列研究
Clin Transl Radiat Oncol. 2025 Jun 27;54:101006. doi: 10.1016/j.ctro.2025.101006. eCollection 2025 Sep.
3
Metronomic S-1 Adjuvant Chemotherapy Improves Survival in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma.节拍式 S-1 辅助化疗可改善局部晚期鼻咽癌患者的生存。
Cancer Res Treat. 2024 Oct;56(4):1058-1067. doi: 10.4143/crt.2023.1343. Epub 2024 Feb 19.
4
Reducing Target Volumes of Intensity Modulated Radiation Therapy After Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: Long-Term Results of a Prospective, Multicenter, Randomized Trial.诱导化疗后局部晚期鼻咽癌调强放疗靶区体积缩小：前瞻性、多中心、随机试验的长期结果。
Int J Radiat Oncol Biol Phys. 2023 Nov 15;117(4):914-924. doi: 10.1016/j.ijrobp.2023.06.001. Epub 2023 Jun 24.
5
Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis.放化疗在调强放疗治疗鼻咽癌患者中的作用（MAC-NPC）：一项更新的个体患者数据网络荟萃分析。
Lancet Oncol. 2023 Jun;24(6):611-623. doi: 10.1016/S1470-2045(23)00163-8.
6
Efficacy and Safety of Concurrent Chemoradiotherapy Combined With Induction Chemotherapy or Adjuvant Chemotherapy in Patients With Stage II-IVA Nasopharyngeal Carcinoma: A Propensity Score Matching Analysis and Meta-Analysis.同步放化疗联合诱导化疗或辅助化疗治疗II-IVA期鼻咽癌患者的疗效和安全性：倾向评分匹配分析和Meta分析
Front Oncol. 2021 Dec 3;11:778836. doi: 10.3389/fonc.2021.778836. eCollection 2021.
7
Clinical endpoints in oncology - a primer.肿瘤学中的临床终点——入门指南。
Am J Cancer Res. 2021 Apr 15;11(4):1121-1131. eCollection 2021.
8
Censoring in clinical trials: review of survival analysis techniques.临床试验中的删失数据：生存分析技术综述
Indian J Community Med. 2010 Apr;35(2):217-21. doi: 10.4103/0970-0218.66859.
Zotero 插件